Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2765)
All Articles published online
|
Jun 14, 2008 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang XS, Jin R, Zhang SB, Tao ML. Clinical features of adverse reactions associated with telbivudine. World J Gastroenterol 2008; 14(22): 3549-3553 [PMID: 18567085 DOI: 10.3748/wjg.14.3549] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i22/3549.htm |
| Number | Citing Articles |
| 1 |
George P. H. Leung. Advances in Mitochondrial Medicine. Advances in Experimental Medicine and Biology 2012; 942: 347 doi: 10.1007/978-94-007-2869-1_16
|
| 2 |
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 2008; 17(12) doi: 10.1002/pds.1493
|
| 3 |
Won Young Tak, Soo Young Park, Chang Min Cho, Min Kyu Jung, Seong Woo Jeon, Young Oh Kweon, Ji Young Park, Yoon Kyung Sohn. Clinical, biochemical, and pathological characteristics of clevudine-associated myopathy. Journal of Hepatology 2010; 53(2): 261 doi: 10.1016/j.jhep.2010.03.006
|
| 4 |
Ivana Carey, Phillip M Harrison. Monotherapy versus combination therapy for the treatment of chronic hepatitis B. Expert Opinion on Investigational Drugs 2009; 18(11): 1655 doi: 10.1517/13543780903241599
|
| 5 |
Ji Won Lee, Young Jun Lee, Jong Joon Lee, Jung Ho Kim, Young Kul Jung, Oh Sang Kwon, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim. Efficacy of Entecavir Switching Therapy in Chronic Hepatitis B Patients with Clevudine-induced Myopathy. The Korean Journal of Gastroenterology 2013; 61(1): 30 doi: 10.4166/kjg.2013.61.1.30
|
| 6 |
Jessica A. Brown, Lindsey R. Pack, Jason D. Fowler, Zucai Suo. Presteady State Kinetic Investigation of the Incorporation of Anti-Hepatitis B Nucleotide Analogues Catalyzed by Noncanonical Human DNA Polymerases. Chemical Research in Toxicology 2012; 25(1): 225 doi: 10.1021/tx200458s
|
| 7 |
Min-Hui Liu, Yun-Jian Sheng, Jun-Ying Liu, Huai-Dong Hu, Qiong-Fang Zhang, Hong Ren. Efficacy of telbivudine on interruption of hepatitis B virus vertical transmission: a meta-analysis. Annals of Saudi Medicine 2013; 33(2): 169 doi: 10.5144/0256-4947.2013.169
|
| 8 |
Byung Kook Kim, Jeeyoung Oh, So Young Kwon, Won Hyeok Choe, Soon Young Ko, Kyoung Hoon Rhee, Tae Ho Seo, So Dug Lim, Chang Hong Lee. Clevudine myopathy in patients with chronic hepatitis B. Journal of Hepatology 2009; 51(4): 829 doi: 10.1016/j.jhep.2009.04.019
|
| 9 |
Yan Hong Wang, Ben Quan Wu, Hui Liu. Continuous venovenous hemodiafiltration for hyperlactatemia caused by telbivudine in a patient with chronic hepatitis B: A case report and update review. Journal of Digestive Diseases 2015; 16(3): 164 doi: 10.1111/1751-2980.12173
|
| 10 |
J. Fung, C.-L. Lai, W.-K. Seto, M.-F. Yuen. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B. Journal of Antimicrobial Chemotherapy 2011; 66(12): 2715 doi: 10.1093/jac/dkr388
|
| 11 |
Vandana Khungar, Steven-Huy Han. A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B. Current Hepatitis Reports 2010; 9(2): 75 doi: 10.1007/s11901-010-0039-1
|
| 12 |
Peter Karayiannis. Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis. Scientifica 2012; 2012: 1 doi: 10.6064/2012/478631
|
| 13 |
Tianye He, Bicui Chen, Yaqun Li, Yun Song, Jian Wu, Biyu Xiong, Bin Wang, Jianfei Long. Creatine kinase elevation in chronic hepatitis B patients with telbivudine therapy: influence of telbivudine plasma concentration and single nucleotide polymorphisms of TK2, RRM2B, and NME4. European Journal of Clinical Pharmacology 2024; 80(7): 1029 doi: 10.1007/s00228-024-03674-w
|
| 14 |
Ya-Wen Yang, Meng-Kun Tsai, Ching-Yao Yang, Chih-Yuan Lee, Bor-Luen Chiang, Hong-Shiee Lai. Telbivudine for renal transplant recipients with chronic hepatitis B infection: a randomized controlled trial with early termination. Clinical and Experimental Nephrology 2020; 24(5): 474 doi: 10.1007/s10157-020-01850-7
|
| 15 |
Eun Hye Kim, Hana Park, Kun Ho Lee, Sang Hoon Ahn, Seung-Min Kim, Kwang-Hyub Han. Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B. Clinical and Molecular Hepatology 2013; 19(1): 82 doi: 10.3350/cmh.2013.19.1.82
|
| 16 |
Attur Ravindra Prabhu, Indu Ramachandra Rao, Shankar Prasad Nagaraju, Eti Rajwar, Bhumika T Venkatesh, Sreekumaran Nair N, Ganesh Pai, Nageswara P Reddy, Deepak Suvarna. Interventions for dialysis patients with hepatitis C virus (HCV) infection. Cochrane Database of Systematic Reviews 2023; 2023(4) doi: 10.1002/14651858.CD007003.pub3
|
| 17 |
X. J. Zou, X. Q. Jiang, D. Y. Tian. Clinical features and risk factors of creatine kinase elevations and myopathy associated with telbivudine. Journal of Viral Hepatitis 2011; 18(12): 892 doi: 10.1111/j.1365-2893.2010.01412.x
|
| 18 |
Avin Ramanjooloo, Raymond J Andersen, Archana Bhaw-Luximon. Marine Sponge-Derived/Inspired Drugs and Their Applications in Drug Delivery Systems. Future Medicinal Chemistry 2021; 13(5): 487 doi: 10.4155/fmc-2020-0123
|
| 19 |
Josef Finsterer, Leyla Ay. Myotoxicity of telbivudine in pre-existing muscle damage. Virology Journal 2010; 7(1) doi: 10.1186/1743-422X-7-323
|
| 20 |
Yanni YN Lui, Henry LY Chan. A review of telbivudine for the management of chronic hepatitis B virus infection. Expert Opinion on Drug Metabolism & Toxicology 2008; 4(10): 1351 doi: 10.1517/17425255.4.10.1351
|
| 21 |
Bircan Kayaaslan, Rahmet Guner. Adverse effects of oral antiviral therapy in chronic hepatitis B. World Journal of Hepatology 2017; 9(5): 227-241 doi: 10.4254/wjh.v9.i5.227
|
| 22 |
Ravindra A Prabhu, Sreekumar Nair, Ganesh Pai, Nageswara P Reddy, Deepak Suvarna. Interventions for dialysis patients with hepatitis C virus (HCV) infection. Cochrane Database of Systematic Reviews 2015; 2015(8) doi: 10.1002/14651858.CD007003.pub2
|
| 23 |
Ming-Tsung Lin, Yi-Hao Yen, Ming-Chao Tsai, Po-Lin Tseng, Kuo-Chin Chang, Cheng-Kun Wu, Tsung-Hui Hu, Seung Up Kim. Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice. PLOS ONE 2016; 11(11): e0165416 doi: 10.1371/journal.pone.0165416
|
| 24 |
Michèle G. DuVal, Vijaya K. Hinge, Natalie Snyder, Richard Kanyo, Jenna Bratvold, Edward Pokrishevsky, Neil R. Cashman, Nikolay Blinov, Andriy Kovalenko, W. Ted Allison. Tryptophan 32 mediates SOD1 toxicity in a in vivo motor neuron model of ALS and is a promising target for small molecule therapeutics. Neurobiology of Disease 2019; 124: 297 doi: 10.1016/j.nbd.2018.11.025
|
| 25 |
Eileen L. Yoon, Hyung Joon Yim, Hyun Jung Lee, Young Sun Lee, Jeong Han Kim, Eun Suk Jung, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Hong Sik Lee, Soon Ho Um, Kwan Soo Byun. Comparison of Clevudine and Entecavir for Treatment-naive Patients With Chronic Hepatitis B Virus Infection. Journal of Clinical Gastroenterology 2011; 45(10): 893 doi: 10.1097/MCG.0b013e31821f8bdf
|
| 26 |
Yanni YN Lui, Henry LY Chan. Treatment of chronic hepatitis B: focus on telbivudine. Expert Review of Anti-infective Therapy 2009; 7(3): 259 doi: 10.1586/eri.09.6
|